Publisher
Springer Science and Business Media LLC
Reference285 articles.
1. Cazzola, M. Myelodysplastic syndromes. N. Engl. J. Med. 383, 1358–1374 (2020). This review article discusses definitions, pathophysiology, diagnosis, risk stratification and therapy of MDS.
2. Bejar, R., Levine, R. & Ebert, B. L. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J. Clin. Oncol. 29, 504–515 (2011).
3. Giagounidis, A. & Haase, D. Morphology, cytogenetics and classification of MDS. Best Pract. Res. Clin. Haematol. 26, 337–353 (2013).
4. Ma, X. Epidemiology of myelodysplastic syndromes. Am. J. Med. 125 (Suppl. 7), S2–S5 (2012). This review article discusses the epidemiology of MDS.
5. National Cancer Institute. SEER Cancer Statistics Review, 1975-2016. Myelodysplastic Syndromes (MDS), Chronic Myeloproliferative Disorders (CMD), and Chronic Myelomonocytic Leukemia (CMML). National Cancer Institute http://seer.cancer.gov/csr/1975_2016/browse_csr.php?sectionSEL=30&pageSEL=sect_30_intro.01.html (2022).
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献